DePuy ASR Hip Replacement Lawyers
In August 2010, a DePuy ASR hip recall was issued for approximately 93,000 defective implants after data confirmed a high rate of failure, often requiring revision surgery.
The attorneys at Saiontz & Kirk, P.A. previously reviewed lawsuits for individuals who received a metal-on-metal DePuy ASR hip implant. Cases involving DePuy Pinnacle hip replacements were also reviewed for similar complications.
All cases were handled on a contingency fee basis, with no fees or expenses unless a recovery was obtained.
DEPUY ASR HIP PROBLEMS
The DePuy ASR Acetabular Cup System is a metal-on-metal component used in traditional hip replacements. While the ASR hip resurfacing system was not approved in the U.S., it was used internationally.
A design flaw in the DePuy ASR implant made it difficult to position correctly, increasing the risk of early failure. Improper positioning could cause metal particles to shed into surrounding tissue, resulting in inflammation, bone loss, and long-term complications.
Reported complications included:
- Unexplained Hip Pain
- Loosening of the DePuy ASR Hip
- Hip Failure
- Additional Hip Replacement or Revision Surgery
Individuals with smaller frames or weaker bones were believed to be at higher risk, but complications were reported across a broad population of recipients.
DEPUY ASR HIP REPLACEMENT RECALL
After the ASR hip system was introduced in 2005, DePuy Orthopaedics received increasing complaints of premature failure. Reports to the FDA rose significantly from 2006 to 2009.
In August 2010, DePuy recalled the ASR Hip Resurfacing System and ASR XL Acetabular System, citing revision rates of 12% and 13%, respectively, based on data from the National Joint Registry of England and Wales.
Even patients without current symptoms were advised to contact their surgeons for evaluation.
DEPUY ASR HIP CLASS ACTION LAWYERS
DePuy introduced the ASR metal-on-metal hip implant without sufficient testing, leading to widespread injuries that could have been avoided.
Financial compensation was previously pursued by patients who suffered complications due to the defective ASR hip system. Lawsuits alleged that the manufacturer prioritized profits over patient safety.
